Asparlas™ to require prior authorization for Blue Cross URMBT non-Medicare members, starting Nov. 1
For dates of service on or after Nov. 1, 2021, Asparlas (calasparagase pegol-mknl), HCPCS code J9118, will require prior authorization through AIM Specialty Health®. This drug is covered under the medical benefit.
Prior authorization requirements apply when this drug is administered in an outpatient setting for Blue Cross UAW Retiree Medical Benefits Trust non-Medicare members.
How to submit authorization requests
Submit prior authorization requests to AIM using one of the following methods:
More about the authorization requirements
Authorization isn’t a guarantee of payment. As always, health care practitioners need to verify eligibility and benefits for members.
For additional information on requirements related to drugs covered under the medical benefit for Blue Cross URMBT non-Medicare members, see:
Note: Accredo manages prior authorization requests for additional medical benefit drugs.
We'll update the appropriate drug lists to reflect the information in this message prior to the effective date.
*Clicking this link means that you're leaving the Blue Cross Blue Shield of Michigan and Blue Care Network website. While we recommend this site, we're not responsible for its content.
Posted: July 2021
Line of business: Blue Cross Blue Shield of Michigan